Literature DB >> 19596978

IL-8 regulates mucin gene expression at the posttranscriptional level in lung epithelial cells.

Maria V Bautista1, Yajun Chen, Vessela S Ivanova, Michael K Rahimi, Alan M Watson, Mary C Rose.   

Abstract

Airway inflammation and mucus hypersecretion/overproduction/obstruction are pathophysiological characteristics of cystic fibrosis, asthma, and chronic obstructive pulmonary disease. Up-regulation of airway mucin genes by inflammatory/immune response mediators is one of the major contributors to mucin overproduction. IL-8, a potent proinflammatory mediator and neutrophil chemoattractant, is present at high levels in the airway secretions of such patients. In this study, the effects of IL-8 on expression of two major airway mucin genes, MUC5AC and MUC5B, were evaluated. IL-8 increased the mRNA abundance of both mucin genes in two human respiratory tract-derived cell lines (A549 and NCI-H292) in a time- and concentration-dependent manner. IL-8 also increased MUC5AC and MUC5B mRNA levels in primary normal differentiated human bronchial epithelial cells, with a high concentration of IL-8 required to increase MUC5B mRNA levels. IL-8 did not transcriptionally up-regulate MUC5AC gene expression, but rather increased the stability of the MUC5AC transcript, suggesting regulation at the posttranscriptional level. In addition, IL-8 altered the levels of RNA-binding proteins to specific domains in the 3'-untranslated region of the MUC5AC transcript. Taken together, these data indicate that the IL-8-induced binding of RNA-binding proteins to the 3'-untranslated region of MUC5AC is a potential mechanism for regulating MUC5AC gene expression at the posttranscriptional level, thus suggesting a new role whereby IL-8 sustains mucin gene expression in inflamed airways.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19596978     DOI: 10.4049/jimmunol.0803022

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

Review 1.  Chronic Rhinosinusitis without Nasal Polyps.

Authors:  Seong Ho Cho; Dae Woo Kim; Philippe Gevaert
Journal:  J Allergy Clin Immunol Pract       Date:  2016 Jul-Aug

Review 2.  Innate immunity in the respiratory epithelium.

Authors:  Dane Parker; Alice Prince
Journal:  Am J Respir Cell Mol Biol       Date:  2011-02-17       Impact factor: 6.914

Review 3.  Cross-roads in the lung: immune cells and tissue interactions as determinants of allergic asthma.

Authors:  Lakshmi Ramakrishna; Victor Christoff de Vries; Maria Alicia Curotto de Lafaille
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

4.  Ribosomal protein S3 gene silencing protects against experimental allergic asthma.

Authors:  Jinrui Dong; Wupeng Liao; Hong Yong Peh; Tze Khee Chan; W S Daniel Tan; Li Li; Amy Yong; W S Fred Wong
Journal:  Br J Pharmacol       Date:  2017-02-24       Impact factor: 8.739

5.  Involvement of epidermal growth factor receptor-linked signaling responses in Pseudomonas fluorescens-infected alveolar epithelial cells.

Authors:  Hye Jin Choi; Chan Hee Seo; Seong Hwan Park; Hyun Yang; Kee Hun Do; Juil Kim; Hyung-Kab Kim; Duk-Hwa Chung; Jung Hoon Ahn; Yuseok Moon
Journal:  Infect Immun       Date:  2011-02-22       Impact factor: 3.441

6.  Evaluation of dicarbonyls generated in a simulated indoor air environment using an in vitro exposure system.

Authors:  Stacey E Anderson; Laurel G Jackson; Jennifer Franko; J R Wells
Journal:  Toxicol Sci       Date:  2010-03-03       Impact factor: 4.849

7.  IL-1β induction of MUC5AC gene expression is mediated by CREB and NF-κB and repressed by dexamethasone.

Authors:  Yajun Chen; Lindsay M Garvin; Tracey J Nickola; Alan M Watson; Anamaris M Colberg-Poley; Mary C Rose
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-01-31       Impact factor: 5.464

8.  Neutrophil elastase induces MUC5AC secretion via protease-activated receptor 2.

Authors:  Jia Zhou; Juliy M Perelman; Victor P Kolosov; Xiangdong Zhou
Journal:  Mol Cell Biochem       Date:  2013-02-08       Impact factor: 3.396

Review 9.  Targeting mucus hypersecretion: new therapeutic opportunities for COPD?

Authors:  Clémence Martin; Justine Frija-Masson; Pierre-Régis Burgel
Journal:  Drugs       Date:  2014-07       Impact factor: 9.546

Review 10.  CFTR, mucins, and mucus obstruction in cystic fibrosis.

Authors:  Silvia M Kreda; C William Davis; Mary Callaghan Rose
Journal:  Cold Spring Harb Perspect Med       Date:  2012-09-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.